Gambichler, T.; Rüth, J.; Goesmann, S.; Höxtermann, S.; Skrygan, M.; Susok, L.; Becker, J.C.; Overheu, O.; Schmidt, W.; Reinacher-Schick, A.
A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality. Viruses 2024, 16, 810.
https://doi.org/10.3390/v16050810
AMA Style
Gambichler T, Rüth J, Goesmann S, Höxtermann S, Skrygan M, Susok L, Becker JC, Overheu O, Schmidt W, Reinacher-Schick A.
A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality. Viruses. 2024; 16(5):810.
https://doi.org/10.3390/v16050810
Chicago/Turabian Style
Gambichler, Thilo, Jonas Rüth, Silke Goesmann, Stefan Höxtermann, Marina Skrygan, Laura Susok, Jürgen C. Becker, Oliver Overheu, Wolfgang Schmidt, and Anke Reinacher-Schick.
2024. "A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality" Viruses 16, no. 5: 810.
https://doi.org/10.3390/v16050810
APA Style
Gambichler, T., Rüth, J., Goesmann, S., Höxtermann, S., Skrygan, M., Susok, L., Becker, J. C., Overheu, O., Schmidt, W., & Reinacher-Schick, A.
(2024). A Prospective Study Investigating Immune Checkpoint Molecule and CD39 Expression on Peripheral Blood Cells for the Prognostication of COVID-19 Severity and Mortality. Viruses, 16(5), 810.
https://doi.org/10.3390/v16050810
